Functional interaction of Epidermal growth factor and Angiotensin II in female human primary vascular smooth muscle cells
RNA-seq (gene expression) · human · 44 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 44 samples: 12 conditions, mostly with about 5 replicates eachGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Angiotensin II prevents the metabolic but not the transdifferentiating effect of EGF on vascular smooth muscle cells from human female donorsiScience · 2026
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE292207_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1237390 and SRA study SRP571063. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 44 samples.
How we read this: 12 replicated groups read from 44 sample titles; they account for 44 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8853108 Donor CS1F, HCASMC, control condition, sample group 1 Donor CS1F, HCASMC, con…
- GSM8853109 Donor CS1F, HCASMC, 10 µg/L EGF, sample group 1 Donor CS1F, HCASMC, 10 …
- GSM8853110 Donor CS1F, HCASMC, 10nM AngII, sample group 1 Donor CS1F, HCASMC, 10n…
- GSM8853111 Donor CS1F, HCASMC, 10 µg/L EGF + 10nM AngII, sample group 1 Donor CS1F, HCASMC, 10 …
- GSM8853112 Donor CS1F, HCASMC, control condition, sample group 2 Donor CS1F, HCASMC, con…
- GSM8853113 Donor CS1F, HCASMC, 10 µg/L EGF, sample group 2 Donor CS1F, HCASMC, 10 …
- GSM8853114 Donor CS1F, HCASMC, 10nM AngII, sample group 2 Donor CS1F, HCASMC, 10n…
- GSM8853115 Donor CS1F, HCASMC, 10 µg/L EGF + 10nM AngII, sample group 2 Donor CS1F, HCASMC, 10 …
- GSM8853116 Donor CS1F, HCASMC, control condition, sample group 3 Donor CS1F, HCASMC, con…
- GSM8853117 Donor CS1F, HCASMC, 10 µg/L EGF, sample group 3 Donor CS1F, HCASMC, 10 …
- GSM8853118 Donor CS1F, HCASMC, 10nM AngII, sample group 3 Donor CS1F, HCASMC, 10n…
- GSM8853119 Donor CS1F, HCASMC, 10 µg/L EGF + 10nM AngII, sample group 3 Donor CS1F, HCASMC, 10 …
- GSM8853120 Donor CS1F, HCASMC, control condition, sample group 4 Donor CS1F, HCASMC, con…
- GSM8853121 Donor CS1F, HCASMC, 10 µg/L EGF, sample group 4 Donor CS1F, HCASMC, 10 …
- GSM8853122 Donor CS1F, HCASMC, 10nM AngII, sample group 4 Donor CS1F, HCASMC, 10n…
- GSM8853123 Donor CS1F, HCASMC, 10 µg/L EGF + 10nM AngII, sample group 4 Donor CS1F, HCASMC, 10 …
- GSM8853124 Donor CS1F, HCASMC, control condition, sample group 5 Donor CS1F, HCASMC, con…
- GSM8853125 Donor CS1F, HCASMC, 10 µg/L EGF, sample group 5 Donor CS1F, HCASMC, 10 …
- GSM8853126 Donor CS1F, HCASMC, 10nM AngII, sample group 5 Donor CS1F, HCASMC, 10n…
- GSM8853127 Donor CS1F, HCASMC, 10 µg/L EGF + 10nM AngII, sample group 5 Donor CS1F, HCASMC, 10 …
- GSM8853128 Donor AS2F, HAoSMC, control condition, sample group 6 Donor AS2F, HAoSMC, con…
- GSM8853129 Donor AS2F, HAoSMC, 10 µg/L EGF, sample group 6 Donor AS2F, HAoSMC, 10 …
- GSM8853130 Donor AS2F, HAoSMC, 10nM AngII, sample group 6 Donor AS2F, HAoSMC, 10n…
- GSM8853131 Donor AS2F, HAoSMC, 10 µg/L EGF + 10nM AngII, sample group 6 Donor AS2F, HAoSMC, 10 …
- GSM8853132 Donor AS2F, HAoSMC, control condition, sample group 7 Donor AS2F, HAoSMC, con…
- GSM8853133 Donor AS2F, HAoSMC, 10 µg/L EGF, sample group 7 Donor AS2F, HAoSMC, 10 …
- GSM8853134 Donor AS2F, HAoSMC, 10nM AngII, sample group 7 Donor AS2F, HAoSMC, 10n…
- GSM8853135 Donor AS2F, HAoSMC, 10 µg/L EGF + 10nM AngII, sample group 7 Donor AS2F, HAoSMC, 10 …
- GSM8853136 Donor AS1F, HAoSMC, control condition, sample group 8 Donor AS1F, HAoSMC, con…
- GSM8853137 Donor AS1F, HAoSMC, 10 µg/L EGF, sample group 8 Donor AS1F, HAoSMC, 10 …
- GSM8853138 Donor AS1F, HAoSMC, 10nM AngII, sample group 8 Donor AS1F, HAoSMC, 10n…
- GSM8853139 Donor AS1F, HAoSMC, 10 µg/L EGF + 10nM AngII, sample group 8 Donor AS1F, HAoSMC, 10 …
- GSM8853140 Donor AS1F, HAoSMC, control condition, sample group 9 Donor AS1F, HAoSMC, con…
- GSM8853141 Donor AS1F, HAoSMC, 10 µg/L EGF, sample group 9 Donor AS1F, HAoSMC, 10 …
- GSM8853142 Donor AS1F, HAoSMC, 10nM AngII, sample group 9 Donor AS1F, HAoSMC, 10n…
- GSM8853143 Donor AS1F, HAoSMC, 10 µg/L EGF + 10nM AngII, sample group 9 Donor AS1F, HAoSMC, 10 …
- GSM8853144 Donor AS1F, HAoSMC, control condition, sample group 10 Donor AS1F, HAoSMC, con…
- GSM8853145 Donor AS1F, HAoSMC, 10 µg/L EGF, sample group 10 Donor AS1F, HAoSMC, 10 …
- GSM8853146 Donor AS1F, HAoSMC, 10nM AngII, sample group 10 Donor AS1F, HAoSMC, 10n…
- GSM8853147 Donor AS1F, HAoSMC, 10 µg/L EGF + 10nM AngII, sample group 10 Donor AS1F, HAoSMC, 10 …
+ 4 more — browse all 44 samples with per-sample file links →
- GSE277165 Single-cell transcriptomics and epigenomics point to CD58/CD59-CD2 interactions in controlling primary melanoma growth and immunity 20 samples shares interaction, primary, growth
- GSE327289 Cerebrovascular Single-Nucleus RNA-Seq Reveals Heat Shock Activation and Vascular Remodeling in Alzheimer’s Disease and Primary Tauopathies 76 samples shares vascular, primary
- GSE312780 Blood-flow restriction resistance training improves skeletal muscle mitochondrial oxidative capacity and cardiovascular risk factors in type 2 diabetes 34 samples shares vascular, factor
- GSE281002 Rapid generation of functional vascular organoids via simultaneous transcription factor activation of endothelial and mural lineages 15 samples shares vascular, factor
- GSE317257 Mapping Endothelial-Macrophage Interactions in Diabetic Vasculature: Role of TREM2 in Vascular Inflammation and Ischemic Respons 35 samples shares interaction, vascular
- GSE193413 Super-silencer perturbation by EZH2 and REST inhibition leads to large loss of chromatin interactions and reduction in cancer growth [Hi-C] 28 samples shares interaction, growth
- GSE251729 JMJD1C facilitates long distance genomic interactions by promoting condensates formation of key leukemic transcription factors in multiple AML cells 28 samples shares interaction, factor
- GSE269335 Single-cell multimodal profiling of monocytes reveals diverse phenotypes and alterations linked to cardiovascular disease risks 118 samples shares vascular
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.